Expression of focal adhesion kinase in patients with endometrial cancer a clinicopathologic study

International Journal of Gynecological Cancer

Volumn 19, Issue 7, 2009, Pages 1221-1225

  Gabriel, Boris ^a   Hasenburg, Annette ^a   Waizenegger, Miriam ^a   Orlowska Volk, Marzenna ^a   Stickeler, Elmar ^a   Hausen, Axel Zur ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Endometrial cancer; Focal adhesion kinase; Survival; Tyrosine kinase

Indexed keywords

FOCAL ADHESION KINASE 1; PTK2 PROTEIN, HUMAN; TUMOR MARKER;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CAUSE OF DEATH; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; CANCER STAGING; CARCINOMA; COHORT ANALYSIS; DISEASE COURSE; ENDOMETRIUM TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 73449139153     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181b33c61     Document Type: Article

References (22)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
2. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci. 2003;116:1409-1416.
3. Schlaepfer DD, Hunter T. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J Biol Chem. 1997;272:13189-13195.
4. McLean GW, Carragher NO, Avizienyte E, et al. The role of focal adhesion kinase in cancerVa new therapeutic opportunity. Nat Rev Cancer. 2005;5:505-515.
5. Owens LV, Xu L, Craven RJ, et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 1995;55: 2752-2755
6. Gabriel B, Mildenberger S, Weisser CW, et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res. 2004;24: 921-928
7. Watermann DO, Gabriel B, Jäger M, et al. Specific induction of pp125 focal adhesion kinase in human breast cancer. Br J Cancer. 2005;93: 694-698
8. Smith CS, Golubovskaya VM, Peck E, et al. Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluoruracil on the viability of melanoma cell lines. Melanoma Res. 2005;15:357-362.
9. Satoh TH, Surmacz TA, Nyormoi O, et al. Inhibition of focal adhesion kinase by antisense oligonucleotides enhances the sensitivity of breast cancer cells to camptothecins. Biocell. 2003;27:47-55.
10. Golubovskaya V, Beviglia L, Xu LH, et al. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptorYmediated apoptosis in human breast cancer cells. J Biol Chem. 2002;277:38978-38987.
11. Gabriel B, zur Hausen A, Stickeler E, et al. Weak expression of Focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin Cancer Res. 2006;12: 2476-2483.
12. Cance WG, Harris JE, IacoccaMV, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 2000;6:2417-2423.
13. Livasy CA, Moore D, Cance WG, et al. Focal adhesion kinase overexpression in endometrial neoplasia. Appl Immunohistochem Mol Morphol. 2004;12:342-345.
14. van Nimwegen MJ, Verkoeijen S, van Buren L, et al. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. 2005;65: 4698-4706.
15. Acconcia F, Barnes CJ, Kumar R. Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells. Endocrinology. 2006;147:1203-1212.
16. Chi DS, Barakat RR, Palayekar MJ, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 2008;18:269-273.
17. Wright JD, Fiorelli J, Schiff PB, et al. Racial disparities for uterine corpus tumors. Changes in clinical characteristics and treatment over time. Cancer. 2009;115:1276-1285.
18. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16:481-488.
19. Halder J, Kamat AA, Landen CN Jr, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian cancer therapy. Clin Cancer Res. 2006;12: 4916-4924.
20. Duxbury MS, Ito H, Benoit E, et al. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem Biophys Res Commun. 2003;311:786-792.
21. Melkoumian ZK, Peng X, Gan B, et al. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res. 2005;65:6676-6684.
22. Chan JK, Wu H, Cheung MK, et al. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol. 2007;106:282-288.